QTREX Quantum

QTREX Quantum, formerly known as Inspira Technologies Oxy B.H.N. Ltd., is an Israeli-based company headquartered in Ra'anana, Israel. Founded in 2018, the company recently underwent a significant strategic transformation. While previously focused on innovative medical devices for respiratory support, it officially changed its corporate name to QTREX Quantum and its Nasdaq ticker from IINN to QTEX on May 20, 2026, to reflect a new primary strategic focus on Additively Manufactured Electronics (AME) and quantum connectivity.

Prior to its strategic pivot, Inspira Technologies developed proprietary life support technologies aimed at treating acute respiratory failure, offering alternatives to invasive mechanical ventilation. Key medical products included the INSPIRA ART100 system, FDA 510(k) cleared for cardiopulmonary bypass in the U.S. and approved for ECMO procedures outside the U.S., and the INSPIRA ART500, an augmented respiration technology designed to elevate oxygen saturation levels while patients remain awake. The company also developed the HYLA blood sensor for real-time continuous blood parameter monitoring. Under its new identity as QTREX Quantum, the company's core offerings now center on its AME platform for advanced manufacturing and high-performance electronics, particularly for quantum computing connectivity.

Under the leadership of CEO Dagi Ben-Noon, QTREX Quantum is actively pursuing its new strategic direction, which includes the acquisition of Nano Dimension's AME platform and a joint development agreement with Qarakal Quantum. The company has secured government grants and orders for its AME systems and is showcasing related components. Concurrently, QTREX Quantum plans to monetize its medical business by Q3 2026, while still fulfilling existing orders for its medical devices, such as a recent purchase order for the ART100 system from NYU Langone in May 2026. The company has also restructured its executive team and terminated certain financing agreements to align with its evolving capital structure and strategic goals.